Analysts expect Janux Therapeutics, Inc. to report revenue of 8.58 M for Q3 26, against a range of 7.74 M to 9.41 M. The most recent reported quarter, Q2 26, came in at 10.27 M, a 42.6% miss against the 17.88 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 439,000.00 | 0.00 | 0.00 | 0.00 | 10.00 M | 0.00 | 3.73 M | 10.27 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.67 M | 449,716.00 | 606,465.52 | 289,824.29 | 3.25 M | 92,216.11 | 4.97 M | 18.75 M | 9.41 M | 7.94 M | 2.71 M | 2.65 M | 6.15 M | 4.62 M | 881,982.18 | 1.71 M | ||||||||||
| Low Estimate | 1.47 M | 406,344.54 | 522,993.94 | 244,511.05 | 2.81 M | 80,715.31 | 4.22 M | 17.01 M | 7.74 M | 7.46 M | 2.48 M | 2.21 M | 5.37 M | 3.89 M | 815,675.08 | 1.42 M | ||||||||||
| Consensus Estimate | 1.57 M | 428,030.27 | 564,729.73 | 267,167.67 | 3.03 M | 86,465.71 | 4.60 M | 17.88 M | 8.58 M | 7.70 M | 2.60 M | 2.43 M | 5.76 M | 4.25 M | 848,828.63 | 1.57 M |
Analysts expect Janux Therapeutics, Inc. to report earnings per share of -0.45 for Q3 26, against a range of -0.49 to -0.41. The most recent reported quarter, Q2 26, came in at -0.35, a 34.6% miss against the -0.26 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.51 | -0.36 | -0.38 | -0.55 | -0.39 | -0.51 | -0.39 | -0.35 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.32 | -0.39 | -0.33 | -0.45 | -0.52 | -0.53 | -0.52 | -0.24 | -0.41 | -0.52 | -0.67 | -0.61 | -0.58 | -0.60 | -0.74 | -0.82 | ||||||||||
| Low Estimate | -0.36 | -0.47 | -0.39 | -0.53 | -0.62 | -0.65 | -0.62 | -0.28 | -0.49 | -0.60 | -0.71 | -0.69 | -0.62 | -0.68 | -0.84 | -0.98 | ||||||||||
| Consensus Estimate | -0.34 | -0.43 | -0.36 | -0.49 | -0.57 | -0.59 | -0.57 | -0.26 | -0.45 | -0.56 | -0.69 | -0.65 | -0.60 | -0.64 | -0.79 | -0.90 |
Pull Wall Street consensus for Janux Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=JANX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "JANX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=JANX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();